Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
16/01/2026
Bank of England Governor Bailey: We must fight back, and we must do so with action rather than words.
Latest
2 m ago
Due to the surge in natural gas prices, the 5-year Euro CPI swap contract has reached its highest level since September last year.
3 m ago
Hanwei Technology: Intending to publicly issue H shares overseas and list on the Hong Kong Stock Exchange.
4 m ago
The number of artificial intelligence companies in our country exceeds 6,200.
4 m ago
According to Every AI Quick News, Sinodata Securities published a research report on January 16th, giving a "buy" rating to Shanwaishan (688410.SH). The rating reasons mainly include: 1) China's hemodialysis equipment market is expected to exceed 50 billion yuan by 2030, with potential demand growth driven by policies such as the construction of medical consortia, benefiting Shanwaishan's domestic hemodialysis machine as a leader in import substitution; 2) Shanwaishan has a full product line layout in the field of blood purification "equipment-consumables", focusing on technology to establish product strength advantage; 3) Long-term development: deepening "research and innovation + global layout", accelerating towards becoming an international leader in blood purification. (Daily Economic News)
4 m ago
The 17th People's Congress of Dalian held its fifth meeting on January 16th and elected Li Qiang as the Mayor of Dalian People's Government.
See all latest